HomeInsightsResults

Prism Medico & Pharmacy Ltd Quarterly Result

Prism Medico & Pharmacy Ltd Quarterly Result

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

13.4 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Prism Medico & Pharmacy Ltd

NSE: PRISMMEDICO

Net Profit

₹ -0.04

Last updated on: Nov 24, 2024

Key Highlights

  • The revenue of Prism Medico & Pharmacy Ltd for the Sep '24 is ₹ 0.29 crore as compare to the Jun '24 revenue of ₹ 0.06 crore. This represent the growth of 383.3333%.
  • The ebitda of Prism Medico & Pharmacy Ltd for the Sep '24 is ₹ 0.01 crore as compare to the Jun '24 ebitda of ₹ -0.09 crore. This represent the decline of -111%.
  • The net profit of Prism Medico & Pharmacy Ltd for the Sep '24 is ₹ 0.01 crore as compare to the Jun '24 net profit of ₹ -0.09 crore. This represent the decline of -111%.

Results Analysis

Market Price of Prism Medico & Pharmacy Ltd

1M

1Y

3Y

5Y

Monitoring Prism Medico & Pharmacy Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202425.58
21 Nov 202425.18
19 Nov 202425.66
18 Nov 202425.95
14 Nov 202426
13 Nov 202427.05
12 Nov 202428.28
11 Nov 202427.82
08 Nov 202428
07 Nov 202427.8

Historical Revenue of Prism Medico & Pharmacy Ltd

No data available

* All values are in crore

Historical EBITDA of Prism Medico & Pharmacy Ltd

No data available

* All values are in crore

Historical Net Profit of Prism Medico & Pharmacy Ltd

No data available

* All values are in crore

Prism Medico & Pharmacy Ltd News Hub

News

Prism Medico and Pharmacy to table results

Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on ...

Read more

08 Nov 202416:58

News

Prism Medico and Pharmacy AGM scheduled

Prism Medico and Pharmacy announced that the Annual General Meeting (AGM) of the company w...

Read more

18 Sep 202416:36

News

Prism Medico and Pharmacy to conduct board meeting

Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on ...

Read more

03 Sep 202411:03

News

Prism Medico and Pharmacy to hold board meeting

Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on ...

Read more

12 Aug 202410:32

News

Prism Medico and Pharmacy to table results

Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on ...

Read more

25 May 202416:33

News

Prism Medico and Pharmacy to hold board meeting

Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on ...

Read more

06 Feb 202412:09

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Prism Medico Pharmacy Ltd Quarterly Result

What is the EPS of Prism Medico & Pharmacy Ltd stock?

The Earnings Per Share (EPS) of Prism Medico & Pharmacy Ltd is 0.07. An EPS is the amount of net income attributed to each share of a common stock.

How is Prism Medico & Pharmacy Ltd EPS calculated?

The EPS of Prism Medico & Pharmacy Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Prism Medico & Pharmacy Ltd report its EPS?

Prism Medico & Pharmacy Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Prism Medico & Pharmacy Ltd EPS?

Factors that influence the EPS of Prism Medico & Pharmacy Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Prism Medico & Pharmacy Ltd EPS growth indicate future performance?

Yes, consistent growth in Prism Medico & Pharmacy Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*